In addition, mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from enhanced R&D activities and medication adherence to securing the supply chain and combating counterfeit drugs. Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for over $23 Billion in 2017 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of more than 35% over the next three years.
The “mHealth Mobile Healthcare Ecosystem: 2017-2030-Opportunities, Challenges, Strategies & Forecasts“ report presents an in–depth assessment of the global mHealth market. In addition to covering key market drivers, challenges, future roadmap, value chain analysis, deployment case studies, service/product strategies and strategic recommendations, the report also presents comprehensive forecasts for the mHealth market from 2017 till 2030. The forecasts and historical revenue figures are individually segmented for 5 individual submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries. The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend. As healthcare service providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost–efficiency. mHealth refers to the usage of mobile communications technology and devices to enhance access to healthcare information, improve distribution of routine and emergency health services, and provide diagnostic services.
Mobile operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services as a growing proportion of their subscribers adopt healthcare centric wearables. Given that most operators have established themselves as reputable consumer brands, they are also eyeing at opportunities to offer services beyond simple connectivity. Many operators already offer branded or co-branded end-to-end mHealth solutions to their customer bases.
Key Findings The report has the following key findings: Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for over $23 Billion in 2017 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of more than 35% over the next three years. While the use of mHealth devices and apps is already widespread in clinical trials, pharmaceutical giants are now setting their sights on connected drug delivery platforms that will automatically detect and log patients’ medication use to improve adherence. SNS Research estimates that mHealth centric wearable devices will account for over 60 Million unit shipments by the end of 2017. In order to gain valuable insights from the data generated by these devices, healthcare service providers and other stakeholders are increasingly investing in Big Data and analytics technology. mHealth has the potential to dramatically reduce the costs of healthcare operations, while improving the quality of healthcare. SNS Research estimates that by the end of 2017, mHealth could represent up to $370 Billion in annual healthcare cost savings worldwide.
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
